Category: Business news
-
CEI LabForce awarded $1 million for biosciences workforce training program
The Center for Entrepreneurial Innovation LabForce was awarded $1 million to support a new biomedical technician training program on the Phoenix Bioscience Core.
-
850 PBC welcomes three new tenants in genomics and diagnostics
The newest development on the Phoenix Bioscience Core, 850 PBC, recently welcomed three new companies in the areas of genomics research and medical diagnostics.
-
PBC Company Calviri announces enrollment of 800 dogs in preventative cancer vaccine trial
Vaccine Against Canine Cancer Study (VACCS), with 800 dogs, making it the largest interventional canine clinical trial in the history of veterinary medicine.
-
Calviri CEO Dr. Stephen Johnston on cancer eradication
Phoenix Bioscience Core-based Calviri Inc.’s founder Dr. Stephen Johnston recently spoke to Progress, Potential and Possibilities on eradicating cancer via a universival preventative cancer vaccine.
-
Slideshow: Wexford Science + Technology plans new innovation labs at 850 PBC
Wexford Science & Technology, LLC, a national innovation district developer that partners exclusively with universities, academic medical centers, and research institutions, is launching the Wexford Innovation Labs at 850 PBC, the firm’s newest development located in the Phoenix Bioscience Core.
-
Calviri announces new scientific advisory board
The newly formed Scientific Advisory Board will collaborate closely with Calviri’s senior leadership team and support the advancement of the company’s diversified portfolio of diagnostic platforms and therapeutic cancer vaccines pipeline targeting both human and animal health.
-
OncoMyx appoints Robert Williamson Chief Business and Chief Financial Officer
OncoMyx Therapeutics, a privately-held oncolytic virus immunotherapy company, today announced the appointment of Robert Williamson as Chief Business and Chief Financial Officer.
